Fidelity Investments
CYTO

Fidelity Investments’s Altamira Therapeutics Ltd CYTO Stock Holding History

Fidelity Investments’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-19
Closed -$6.47M – 2710
2016
Q2 		$6.47M Hold
19
– – ﹤0.01% 2124
2016
Q1 		$5.65M Sell
19
-2
-10% -$712K ﹤0.01% 2124
2015
Q4 		$8.15M Hold
21
– – ﹤0.01% 2057
2015
Q3 		$5.93M Hold
21
– – ﹤0.01% 2126
2015
Q2 		$8.23M Hold
21
– – ﹤0.01% 2087
2015
Q1 		$8.92M Hold
21
– – ﹤0.01% 2041
2014
Q4 		$6.5M Hold
21
– – ﹤0.01% 2144
2014
Q3 		$9.68M Buy
+21
New +$10.4M ﹤0.01% 2029

Other funds holding CYTO

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments's CYTO Position: Q3 2016 in Review

Fidelity Investments sold out of Altamira Therapeutics Ltd (CYTO) in Q3 2016, closing a stake of 19 shares — an estimated $6.47M sold.

Fidelity Investments first reported a position in CYTO in Q3 2014 and held it in 8 quarters. The position peaked at $9.68M in Q3 2014. 3 funds tracked by Wall St. Rank hold CYTO as of Q3 2016.

  • Fidelity Investments reported no remaining Altamira Therapeutics Ltd position as of Q3 2016 after selling out during the quarter.
  • Fidelity Investments sold 19 Altamira Therapeutics Ltd shares in Q3 2016, an estimated $6.47M.
  • Fidelity Investments first reported a position in Altamira Therapeutics Ltd in Q3 2014 and held it in 8 quarters.
  • Fidelity Investments's Altamira Therapeutics Ltd position peaked at $9.68M in Q3 2014.
  • 3 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q3 2016.

Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.